S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
MSFT   168.07 (-1.65%)
GOOGL   1,386.32 (-2.36%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
BABA   205.61 (-0.27%)
MU   52.10 (-5.29%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
F   7.23 (-4.49%)
NFLX   360.09 (-2.34%)
PRI   121.42 (-4.37%)
BAC   31.08 (-5.04%)
DIS   128.19 (-3.62%)
GILD   70.10 (-3.84%)
S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
MSFT   168.07 (-1.65%)
GOOGL   1,386.32 (-2.36%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
BABA   205.61 (-0.27%)
MU   52.10 (-5.29%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
F   7.23 (-4.49%)
NFLX   360.09 (-2.34%)
PRI   121.42 (-4.37%)
BAC   31.08 (-5.04%)
DIS   128.19 (-3.62%)
GILD   70.10 (-3.84%)
S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
MSFT   168.07 (-1.65%)
GOOGL   1,386.32 (-2.36%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
BABA   205.61 (-0.27%)
MU   52.10 (-5.29%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
F   7.23 (-4.49%)
NFLX   360.09 (-2.34%)
PRI   121.42 (-4.37%)
BAC   31.08 (-5.04%)
DIS   128.19 (-3.62%)
GILD   70.10 (-3.84%)
S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
MSFT   168.07 (-1.65%)
GOOGL   1,386.32 (-2.36%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
BABA   205.61 (-0.27%)
MU   52.10 (-5.29%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
F   7.23 (-4.49%)
NFLX   360.09 (-2.34%)
PRI   121.42 (-4.37%)
BAC   31.08 (-5.04%)
DIS   128.19 (-3.62%)
GILD   70.10 (-3.84%)
Log in

Harvard Bioscience SEC Filings & 10K Form (NASDAQ:HBIO)

$2.58
+0.03 (+1.18 %)
(As of 02/25/2020 04:00 PM ET)
Today's Range
$2.46
Now: $2.58
$2.75
50-Day Range
$2.55
MA: $2.92
$3.22
52-Week Range
$1.51
Now: $2.58
$4.66
Volume119,082 shs
Average Volume75,340 shs
Market Capitalization$98.21 million
P/E RatioN/A
Dividend YieldN/A
Beta1.51

SEC Filings

Harvard Bioscience (NASDAQ:HBIO) SEC Filings

DateFilerForm TypeView
02/07/2020
2:11 PM
Harvard Bioscience (Subject)
Potomac Capital Management, Inc. (Filed by)
Form SC 13G/A
01/03/2020
3:41 PM
EDRICK ALAN I (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
3:39 PM
Harvard Bioscience (Issuer)
LOY BERTRAND (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
3:37 PM
Harvard Bioscience (Issuer)
Loewald Thomas W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
3:28 PM
Harvard Bioscience (Issuer)
KENNEDY JOHN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2019
3:30 PM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2019
3:13 PM
EDRICK ALAN I (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2019
3:30 PM
Harvard Bioscience (Issuer)
LOY BERTRAND (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2019
3:06 PM
Green James W (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2019
4:14 PM
Harvard Bioscience (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2019
3:04 PM
Harvard Bioscience (Issuer)
Olson Kenneth Fletcher (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/05/2019
5:03 PM
Harvard Bioscience (Issuer)
Singh Yash (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
3:05 PM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2019
5:55 AM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2019
4:09 PM
Harvard Bioscience (Issuer)
LOY BERTRAND (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2019
3:12 PM
EDRICK ALAN I (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2019
3:17 PM
EDRICK ALAN I (Reporting)
Harvard Bioscience (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/04/2019
4:01 PM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2019
3:19 PM
Harvard Bioscience (Issuer)
Loewald Thomas W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
6:38 AM
Green James W (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2019
4:37 PM
Green James W (Reporting)
Harvard Bioscience (Issuer)
Form 4/A
08/12/2019
4:27 PM
Eade Katherine A. (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2019
4:16 PM
Harvard Bioscience (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2019
3:22 PM
Harvard Bioscience (Issuer)
LOY BERTRAND (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2019
3:19 PM
Harvard Bioscience (Issuer)
Loewald Thomas W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2019
3:16 PM
Eade Katherine A. (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2019
4:46 PM
Harvard Bioscience (Issuer)
Rossi Michael A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2019
4:45 PM
Harvard Bioscience (Issuer)
Rossi Michael A. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/25/2019
3:05 PM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2019
3:50 PM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2019
4:26 PM
ENGINE CAPITAL, L.P. (Filed by)
Harvard Bioscience (Subject)
Form SC 13D
07/17/2019
1:55 PM
Harvard Bioscience (Subject)
Potomac Capital Management, Inc. (Filed by)
Form SC 13G
07/09/2019
3:18 PM
Duchemin Jeffrey (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2019
3:16 PM
Green James W (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2019
7:05 AM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2019
4:15 PM
First Light Asset Management, LLC (Filed by)
Harvard Bioscience (Subject)
Form SC 13G/A
07/01/2019
3:06 PM
Duchemin Jeffrey (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2019
3:16 PM
Harvard Bioscience (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/29/2019
4:07 PM
Duchemin Jeffrey (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
4:30 PM
Harvard Bioscience (Issuer)
LOY BERTRAND (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
4:28 PM
Green James W (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
4:27 PM
Harvard Bioscience (Issuer)
KENNEDY JOHN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
4:25 PM
Eade Katherine A. (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
4:23 PM
Harvard Bioscience (Issuer)
Loewald Thomas W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2019
3:30 PM
Harvard Bioscience (Filer)
Form SD
Specialized Disclosure Report  
05/13/2019
4:01 PM
GRAZIANO CHANE (Filed by)
Harvard Bioscience (Subject)
Form SC 13G/A
05/08/2019
4:01 PM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2019
7:32 AM
Harvard Bioscience (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/12/2019
3:06 PM
Duchemin Jeffrey (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2019
3:18 PM
Harvard Bioscience (Filer)
Form DEF 14A
04/05/2019
3:05 PM
Harvard Bioscience (Filer)
Form DEFA14A
04/02/2019
4:00 PM
Harvard Bioscience (Issuer)
Unninayar Kamalam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2019
4:10 PM
Harvard Bioscience (Filer)
Form 8-K/A
03/18/2019
3:21 PM
Harvard Bioscience (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/28/2019
3:10 PM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/08/2019
8:07 AM
DIMENSIONAL FUND ADVISORS LP (Filed by)
Harvard Bioscience (Subject)
Form SC 13G/A
02/06/2019
3:10 PM
Green James W (Reporting)
Harvard Bioscience (Issuer)
Form 4/A
01/03/2019
3:31 PM
Green James W (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
3:28 PM
Harvard Bioscience (Issuer)
KENNEDY JOHN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
3:18 PM
Harvard Bioscience (Issuer)
LOY BERTRAND (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
3:07 PM
Harvard Bioscience (Issuer)
Unninayar Kamalam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2018
7:30 AM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2018
3:45 PM
Harvard Bioscience (Issuer)
Unninayar Kamalam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2018
3:34 PM
Harvard Bioscience (Issuer)
Unninayar Kamalam (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/07/2018
3:01 PM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2018
3:05 PM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2018
4:00 PM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2018
3:30 PM
First Light Asset Management, LLC (Filed by)
Harvard Bioscience (Subject)
Form SC 13G/A
08/30/2018
3:07 PM
Green James W (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2018
3:04 PM
Gagnon Robert E. (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2018
7:35 AM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2018
3:23 PM
Harvard Bioscience (Issuer)
Sun Yong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2018
3:12 PM
Harvard Bioscience (Issuer)
Sun Yong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2018
3:10 PM
Gagnon Robert E. (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2018
3:09 PM
Duchemin Jeffrey (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2018
4:00 PM
Duchemin Jeffrey (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2018
3:20 PM
Gagnon Robert E. (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2018
5:57 PM
Harvard Bioscience (Issuer)
Sun Yong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2018
3:02 PM
Harvard Bioscience (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2018
3:08 PM
Gagnon Robert E. (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2018
6:13 PM
Gagnon Robert E. (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2018
3:05 PM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/23/2018
3:54 PM
Gagnon Robert E. (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2018
4:10 PM
Gagnon Robert E. (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2018
8:45 PM
Gagnon Robert E. (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2018
7:12 PM
Duchemin Jeffrey (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2018
3:25 PM
Harvard Bioscience (Issuer)
KENNEDY JOHN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2018
3:02 PM
Harvard Bioscience (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/29/2018
3:47 PM
Harvard Bioscience (Issuer)
Loewald Thomas W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2018
3:45 PM
Harvard Bioscience (Issuer)
KENNEDY JOHN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2018
3:43 PM
Eade Katherine A. (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2018
3:39 PM
Harvard Bioscience (Issuer)
LOY BERTRAND (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2018
3:36 PM
Harvard Bioscience (Issuer)
Sun Yong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2018
3:33 PM
Green James W (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2018
3:23 PM
Duchemin Jeffrey (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2018
8:00 AM
Harvard Bioscience (Filer)
Form SD
Specialized Disclosure Report  
05/10/2018
3:02 PM
Harvard Bioscience (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2018
11:15 PM
Harvard Bioscience (Filer)
Form EFFECT
05/08/2018
3:19 PM
Gagnon Robert E. (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2018
3:05 PM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 2/25/2020 by MarketBeat.com Staff

Featured Article: Inverted Yield Curve

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel